438625-59-3Relevant academic research and scientific papers
Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(-)-HHMA): Comparison with related catecholamines
Felim, Anne,Herrera, Guadalupe,Neudoerffer, Anne,Blanco, Manuel,O'Connor, Jose-Enrique,Largeron, Martine
, p. 211 - 219 (2010)
(±)-3,4-Methylenedioxymethamphetamine (MDMA, also known as "ecstasy") is a chiral drug that is essentially metabolized in humans through O-demethylenation into 3,4-dihydroxymethamphetamine (HHMA). There has recently been a resurgence of interest in the po
Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
-
Page 9; 22, (2008/06/13)
The present invention comprises novel analogs of ecstasy-class compounds and novel ecstasy-class immunogens leashed out of, i.e., derived from, the methylenedioxy position. The invention also comprises unique monoclonal antibodies generated using MDO-leashed MDMA immunogens as well as unique conjugates and tracers. These antibodies, conjugates, and tracers are useful in immunoassays for the detection of ecstasy-class compounds in biological fluids.
